Firstsource Solutions targets double-digit growth despite healthcare deal termination

Investment View and Valuation

In its September 30, 2026 management-meet update on Firstsource Solutions, Emkay Global Financial Services retained its REDUCE recommendation and Rs 270 target price. The broker remains constructive on the company’s medium-term growth strategy, but the target implied only 8.4 per cent upside from the Rs 249 current market price (CMP).

Emkay rolled its valuation forward to September 2028 estimated EPS after revising its currency assumptions, while retaining the target price.

Technology-Led Growth Strategy

Management, represented by CEO Ritesh Idnani, said Firstsource Solutions is positioned for the business-process management sector’s transition from labour-arbitrage outsourcing towards technology-led and outcome-oriented services. Clients increasingly seek domain-led partners that can advise, implement and operate workflows.

Firstsource Solutions is embedding AI into workflows and sees an opportunity to digitise processes that still rely on outdated standard operating procedures. The company is also broadening its portfolio into marketing, security, AI training datasets and collections, including a voice-agent stack for collections.

Growth and Margin Outlook

Management retained FY27 guidance for constant-currency revenue growth of 10 to 13 per cent and EBIT margin of 12.25 to 12.75 per cent. It expects the second half to outperform the first half and is targeting an EBIT margin of 14 to 15 per cent over the next two to three years.

Emkay noted that achieving the revenue-growth guidance implies quarterly compound growth of 1.7 to 3.5 per cent over Q2 to Q4 FY27. The broker expects the termination of a large healthcare BPaaS deal to reduce Firstsource Solutions’ growth trajectory by 1 to 1.5 per cent, making the upper end of guidance largely unlikely.

Although the termination is negative for sentiment, Emkay does not consider it structurally negative. A provision related to a client indemnity matter could be covered by insurance, which may provide an offset in coming quarters.

Organic Growth Drivers and Deal Pipeline

Management’s double-digit organic-growth aspiration rests on several factors:

• Deeper wallet share and client mining within the existing account base.
• Addition of new strategic clients.
• Expansion into newer geographies, including Canada and the Middle East after Australia.
• Development of new service lines.

Physical AI is largely project based and can therefore be lumpier than the traditional annuity business. The deal pipeline is moving towards larger and longer engagements, with usual tenures of three to five years. A growing proportion of deals have annual contract value above US$5 million, alongside US$20 million to US$25 million opportunities and select US$40 million to US$50 million opportunities.

Transformation-led engagements can ramp gradually and create near-term revenue variability. However, management’s outcome-based commercial constructs could provide around 300 to 500 basis points of margin uplift over comparable full-time-equivalent priced models.

Emkay’s Financial Estimates

Emkay believes Firstsource Solutions is well positioned for industry changes because of its focus on regulated industries and its growing AI- and software-enabled managed-services portfolio. The broker’s revised estimates raise FY27 revenue by 1.0 per cent to Rs 112,473 million, EBIT by 1.4 per cent to Rs 14,180 million and PAT by 1.6 per cent to Rs 9,130 million.

Key Risks

• Slower deal ramps and execution against growth and margin guidance.
• The termination of the healthcare contract.
• Project-related lumpiness in physical AI.
• Near-term revenue variability from gradually ramping transformation-led engagements.